Results 1 to 10 of about 121,688 (235)
Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects [PDF]
Frontiers in Microbiology, 2018 Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control.
Shio-Shin Jean +8 more
doaj +6 more sources
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections [PDF]
Emerging Infectious Diseases, 2014 We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012.
Matthew E. Falagas +3 more
doaj +4 more sources
Paediatric Enterobacteriaceae infections in hospitalised children in Durban, KwaZulu-Natal
Southern African Journal of Infectious Diseases, 2021 Background: Community-acquired Gram-negative Enterobacteriaceae infections in malnourished and HIV-infected hospitalised children are not well documented and are of concern because of increasing antibiotic resistance and limited available treatment ...
Harshna Krishinchand +3 more
doaj +2 more sources
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children. [PDF]
J Pediatric Infect Dis Soc, 2020 AbstractInfections due to carbapenem-resistant Enterobacteriaceae (CRE) are increasingly prevalent in children and are associated with poor clinical outcomes. Optimal treatment strategies for CRE infections continue to evolve. A lack of pediatric-specific comparative effectiveness data, uncertain pediatric dosing regimens for several agents, and a ...
Chiotos K, Hayes M, Gerber JS, Tamma PD.
europepmc +4 more sources
Carbapenem-Resistant Enterobacteriaceae Infections in Children. [PDF]
Curr Infect Dis Rep, 2016 Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear.
Chiotos K, Han JH, Tamma PD.
europepmc +8 more sources
Carbapenem and colistin resistance in children with Enterobacteriaceae infections [PDF]
The Turkish Journal of Pediatrics, 2020 Background. Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. As a reserve agent, colistin has been the drug of choice for the treatment of infections caused by CRE.
Zeliha Haytoğlu +5 more
doaj +3 more sources
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections. [PDF]
Virulence, 2017 In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and represents an important threat to global health. The optimal therapeutic management of carbapenem-resistant Enterobacteriaceae (CRE) infections has not been established, because to date, no clinical trials have been performed with this objective.
Trecarichi EM, Tumbarello M.
europepmc +4 more sources
Management of carbapenem-resistant Enterobacteriaceae infections [PDF]
Clinical Microbiology and Infection, 2019 Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly spread worldwide among clinical isolates of Enterobacteriaceae, mostly Klebsiella spp., and is associated with diverse molecular mechanisms. Carbapenem resistance is often associated with resistance
Durante-Mangoni, Emanuele +2 more
openaire +3 more sources
Antibiotic resistance pattern of clinical isolates of ESBL strains and determination of enzymatic relationship with clinical specimen type [PDF]
مجله پزشکی دانشگاه علوم پزشکی تبریز, 2020 Background: Differences in clinical isolates may affect the frequency of Extended Spectrum Beta-Lactamase enzymes (ESBLs) in some gram-negative bacteria.
Mahyar Porbaran +2 more
doaj +1 more source
In vitro activity of tigecycline against local clinical isolates of some Enterobacteriaceae
Zagazig Journal of Pharmaceutical Sciences, 2020 Infectious diseases that Enterobacteriaceae cause are spreading on a wide scale. Examples of these infections are gastrointestinal tract infections, meningitis, pneumonia, septicemia, urinary tract infections, and wound infections. Antibiotic resistance
Hadeel Eldeeb +3 more
doaj +1 more source